Magnevist® Injection Enhanced MRA at Two Dose Levels Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Infrarenal Aorta and Peripheral Arteries

This study has been completed.

Study NCT00185276 Information provided by Bayer

First Received: September 10, 2005 Last Updated: July 7, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	August 2004
Estimated Primary Completion Date:	No date given